These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25858708)

  • 21. Revisiting induction chemotherapy for head and neck cancer. References and reviews.
    Argiris A; Jayaram P; Pichardo D
    Oncology (Williston Park); 2005 Jun; 19(7):932-4, 939; discussion 939-45. PubMed ID: 16053039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group.
    Lacas B; Carmel A; Landais C; Wong SJ; Licitra L; Tobias JS; Burtness B; Ghi MG; Cohen EEW; Grau C; Wolf G; Hitt R; Corvò R; Budach V; Kumar S; Laskar SG; Mazeron JJ; Zhong LP; Dobrowsky W; Ghadjar P; Fallai C; Zakotnik B; Sharma A; Bensadoun RJ; Ruo Redda MG; Racadot S; Fountzilas G; Brizel D; Rovea P; Argiris A; Nagy ZT; Lee JW; Fortpied C; Harris J; Bourhis J; Aupérin A; Blanchard P; Pignon JP;
    Radiother Oncol; 2021 Mar; 156():281-293. PubMed ID: 33515668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Network meta-analyses: Interest and limits in oncology].
    Ribassin-Majed L; Pignon JP; Michiels S; Blanchard P
    Bull Cancer; 2016 Mar; 103(3):289-93. PubMed ID: 26917469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Revisiting induction chemotherapy for head and neck cancer.
    Argiris A; Jayaram P; Pichardo D
    Oncology (Williston Park); 2005 May; 19(6):759-70. PubMed ID: 15971451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction Chemotherapy and Sequential Concomitant Chemo-radiation in Locally Advanced Head and Neck Cancers: How Induction-phase Intensity and Treatment Breaks May Impact on Clinical Outcomes.
    Franco P; Potenza I; Schena M; Riva G; Pecorari G; Garzino Demo P; Fasolis M; Moretto F; Garzaro M; Di Muzio J; Melano M; Airoldi M; Ragona R; Rampino M; Ricardi U
    Anticancer Res; 2015 Nov; 35(11):6247-54. PubMed ID: 26504058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined-modality therapy of head and neck cancer.
    Vokes EE
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 9):27-30. PubMed ID: 9330405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
    Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
    Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered fractionation radiotherapy in head and neck cancer: clinical issues and pitfalls of "evidence-based medicine".
    Antognoni P; Corvò R; Zerini D; Orecchia R
    Tumori; 2005; 91(1):30-9. PubMed ID: 15850002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of tumor control and presence of visible necrosis in head and neck cancer patients treated with radiotherapy or radiochemotherapy.
    Kuhnt T; Mueller AC; Pelz T; Haensgen G; Bloching M; Koesling S; Schubert J; Dunst J
    J Cancer Res Clin Oncol; 2005 Nov; 131(11):758-64. PubMed ID: 16088405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A non-randomised, single-centre comparison of induction chemotherapy followed by radiochemotherapy versus concomitant chemotherapy with hyperfractionated radiotherapy in inoperable head and neck carcinomas.
    Graf R; Hildebrandt B; Tilly W; Riess H; Felix R; Budach V; Wust P
    BMC Cancer; 2006 Feb; 6():30. PubMed ID: 16451730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomas.
    Prestwich RJ; Öksüz DÇ; Dyker K; Coyle C; Şen M
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e237-43. PubMed ID: 21620580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative concurrent chemoradiotherapy with mitomycin in advanced squamous cell carcinoma of the head and neck: results from three prospective randomized trials.
    Rewari AN; Haffty BG; Wilson LD; Son YH; Joe JK; Ross DA; Papac RJ; Sasaki CT; Fischer JJ
    Cancer J; 2006; 12(2):123-9. PubMed ID: 16630403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Individual patient data meta-analyses in head and neck carcinoma: what have we learnt?].
    Pignon JP; Baujat B; Bourhis J
    Cancer Radiother; 2005 Feb; 9(1):31-6. PubMed ID: 15804617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.
    Giralt J; Trigo J; Nuyts S; Ozsahin M; Skladowski K; Hatoum G; Daisne JF; Yunes Ancona AC; Cmelak A; Mesía R; Zhang A; Oliner KS; VanderWalde A
    Lancet Oncol; 2015 Feb; 16(2):221-32. PubMed ID: 25596659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review.
    Strojan P; Vermorken JB; Beitler JJ; Saba NF; Haigentz M; Bossi P; Worden FP; Langendijk JA; Eisbruch A; Mendenhall WM; Lee AW; Harrison LB; Bradford CR; Smee R; Silver CE; Rinaldo A; Ferlito A
    Head Neck; 2016 Apr; 38 Suppl 1():E2151-8. PubMed ID: 25735803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis.
    Kim R; Hahn S; Shin J; Ock CY; Kim M; Keam B; Kim TM; Kim DW; Heo DS
    Cancer Res Treat; 2016 Jul; 48(3):907-16. PubMed ID: 26582394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review.
    Murdoch D
    Curr Opin Oncol; 2007 May; 19(3):216-21. PubMed ID: 17414639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Head and neck proton therapy in France: A missed opportunity or a challenge in front of us?
    Thariat J; Calugaru V; Aloi D; Maingon P; Grégoire V
    Cancer Radiother; 2021 Oct; 25(6-7):537-544. PubMed ID: 34272183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Planned neck dissection in the treatment of locally advanced head and neck squamous cell carcinoma].
    Jiang L; Lou JL; Wang KJ; Fang MY; Fu ZF
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):92-96. PubMed ID: 29429177
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of locally advanced or unresectable head and neck cancer.
    Culliney B; Birhan A; Young AV; Choi W; Shulimovich M; Blum RH
    Oncology (Williston Park); 2008 Sep; 22(10):1152-61; discussion 1162-6, 1171-2. PubMed ID: 18935927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.